as on January 14, 2026 at 2:29 am IST
Day's High
10.00%
Upside
52 Week's Low
52 Week's High
6.67%
Downside
416.67%
Upside
Check Aprea Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.4M
EPS (TTM)
-1.96
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-13.8M
Revenue (TTM)
488.2K
Profit Margin
0.00%
Return On Equity TTM
-74.72%
Compare market cap, revenue, PE, and other key metrics of Aprea Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.4M | -99.13% | NA | 0.00% | |
| BUY | $49.0B | 124.12% | 1236.37 | 1.36% | |
| BUY | $118.1B | 101.07% | 32.37 | 31.35% | |
| NA | $37.0B | NA | 630.17 | 1.38% | |
| BUY | $81.4B | 46.53% | 18.42 | 32.13% |
The Aprea Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aprea Therapeutics Inc investment value today
Current value as on today
₹29,043
Returns
Returns from Aprea Therapeutics Inc Stock
Dollar Returns*
₹4,181 (+4.18%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Aprea Therapeutics Inc. Average target price of $7
Get share price movements and forecasts by analysts on Aprea Therapeutics Inc.
What analysts predicted
87.14%UPSIDE
Target Price
$7
Current Price
$0.9
Analyzed by
9 Analysts
Target
$7.00
Aprea Therapeutics Inc target price $7, a slight upside of 87.14% compared to current price of $0.9. According to 9 analysts rating.
Search interest for Aprea Therapeutics Inc Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 74.7% return, outperforming this stock by 149.8%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.7% return, outperforming this stock by 120.4%
Price Dip
![]()
In the last 6 months, APRE stock has moved down by -46.9%
| Organisation | Aprea Therapeutics Inc |
| Headquarters | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
| Industry | Commercial Services |
| CEO | Dr. Oren Gilad Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. John P. Hamill CPA | Senior VP, CFO, Principal Accounting Officer & Secretary |
Dr. Lars B. Abrahmsen Ph.D. | Senior VP & Chief Scientific Officer |
Mr. Brian Wiley | Senior Vice President of Corporate Development & Strategy |
Dr. Michel Afargan Ph.D. | Head of Pharmacology Development |
Mr. Ze'ev Weiss B.Sc., C.P.A. | Chief Business Advisor |
Ms. Andrea Epstein | Controller |
Dr. Oren Gilad Ph.D. | Co-Founder, CEO, President & Director |
Aprea Therapeutics Inc share price today is $0.9 as on at the close of the market. Aprea Therapeutics Inc share today touched a day high of $0.99 and a low of $0.9.
Aprea Therapeutics Inc share touched a 52 week high of $4.65 on and a 52 week low of $0.84 on . Aprea Therapeutics Inc stock price today i.e. is closed at $0.9,which is 80.65% down from its 52 week high and 7.14% up from its 52 week low.
Aprea Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Aprea Therapeutics Inc (APRE) shares with as little as ₹90.274 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.74 in Aprea Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aprea Therapeutics Inc share’s latest price of $0.9 as on January 14, 2026 at 2:29 am IST, you will get 11.1111 shares of Aprea Therapeutics Inc. Learn more about
fractional shares .
Aprea Therapeutics Inc stock has given -99.13% share price returns and 23.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?